Navigation Links
The Parkinson's Disease Foundation awards $950,000 in seed grants

(July 1, 2008, New York, NY) The Parkinson's Disease Foundation (PDF) is pleased to announce awards of $950,000 toward its 2008-2009 International Research Grants and Fellowship Program (IRGFP). The funding will support the research of 19 Parkinson's scientists, chosen on April 11 from a group of almost 100 candidates by a scientific review committee led by Stanley Fahn, M.D., PDF's Scientific Director.

This year's outstanding awardees, who hail from around the world, include two who are investigating paths to new potential therapies for Parkinson's disease (PD): Matthew Goldberg, Ph.D., and Sandra M. Lynch, Ph.D., M.Sc., M.B.A.

Dr. Goldberg, of the UT Southwestern Medical Center at Dallas, TX, now in his second year as a recipient of IRGFP funding, continues his quest to develop an "animal model" for PD one that would reproduce the age-dependent progressive loss of dopamine-producing neurons that underlies the primary symptoms of Parkinson's.

"It is a great honor to be awarded this IRGFP grant," said Dr. Goldberg. "With the support of PDF, we are able to tackle some of the greatest challenges in Parkinson's research: understanding why dopamine neurons progressively die, and developing laboratory animals that spontaneously undergo progressive dopamine neuron loss by similar mechanisms. This would provide an enormously valuable tool for discovering and testing neuroprotective therapies for Parkinson's disease."

Because human clinical trials are very expensive and time-consuming, laboratory animals are needed to rapidly test novel treatments that might slow down or prevent the progressive loss of dopamine-producing neurons that results in Parkinson's. The lack of adequate animal models of progressive neuron loss in the area of the brain most affected in Parkinson's (known as the substantia nigra) has been a major impediment to discovering better treatments for PD.

To address this problem, Dr. Goldberg is working on a new animal model based on the hypothesis that oxidative stress causes PD. He proposes that laboratory mice that are deficient in certain protective antioxidant enzymes, such as superoxide dismutase, in combination with mutations in the genes DJ-1 and Parkin (linked to familial PD), will experience progressive loss of dopamine neurons and other features of PD.

In research of potential treatments, it is important not only to have the means to explore them, as Dr. Goldberg is doing, but to have tangible theories for how they work. This is the focus of the research Dr. Lynch, of the Wadsworth Center of the New York State Department of Health.

Dr. Lynch will be using her grant from PDF to explore a variant of antibodies known as "intrabodies" (called such, because they perform work inside of cells) as a potential treatment for people with PD. She plans to engineer these intrabodies to see if they prevent clumping of the protein alpha-synuclein, which leads to the formation of Lewy bodies already known as a hallmark of PD. Researchers believe that destroying the clumping of alpha-synuclein may stop the disease in its tracks.

Dr. Lynch is hopeful that her efforts will have high potential to move to clinical trials because past evidence has shown antibodies to be effective therapies for other diseases. In Parkinson's models, recent research has revealed that intrabodies can indeed inhibit protein aggregation and toxicity. Dr. Lynch sees the possibility that eventually, engineered intrabodies may be found to halt the loss of dopaminergic neurons in people with Parkinson's disease.

Of this year's IRGFP recipients, PDF Scientific Director, Dr. Stanley Fahn said, "PDF is pleased to have another strong pool of candidates who are focused on understanding and treating Parkinson's. Today, unfortunately, funding for science through the National Institutes of Health (NIH) trails the rate of inflation. This means that programs such as the IRGFP are increasingly important especially for young investigators whose track record for federal funding is not yet well established and whose opportunities for funding are dwindling."

The IRGFP is part of PDF's four-pronged approach to funding Parkinson science. In fiscal year 2009, PDF will contribute more than $4.8 million to support Parkinson's disease research. Since 1957, PDF has funded over $70 million worth of scientific research in Parkinson's disease, supporting the work of leading scientists throughout the world.


Contact: Melissa Barry
Parkinson's Disease Foundation

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. Gender, coupled with diabetes, affects vascular disease development
3. Study links cat disease to flame retardants in furniture and to pet food
4. Humans fostering forest-destroying disease
5. Emerging (disease) markets
6. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
7. Clemson chemists discover new way antioxidants fight debilitating diseases
8. Finding that 1-in-a-billion that could lead to disease
9. Study shows link between alcohol consumption and hiv disease progression
10. Natural chemical found in broccoli helps combat skin blistering disease
11. 60 second test could help early diagnosis of common brain diseases
Post Your Comments:
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/18/2015)... 18, 2015  As new scientific discoveries deepen our ... other healthcare providers face challenges in better using that ... In addition, as more children continue to survive pediatric ... and old age. John M. Maris, M.D ... of Philadelphia (CHOP) . --> John ...
(Date:11/17/2015)... November 17, 2015 Paris ... --> Paris from 17 th ... the biometrics innovation leader, has invented the first combined scanner ... the same scanning surface. Until now two different scanners were ... scanner can capture both on the same surface. This ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Researchers at the ... Institute for Brain Research at MIT have engineered changes ... cut down on "off-target" editing errors. The refined technique ... use of genome editing. Science , ... three of the approximately 1,400 amino acids that make ...
(Date:12/1/2015)... , Dec. 1, 2015 Frost & ... program. This program addresses ways companies can innovate ... --> ... --> ... healthcare, as well as the disrupting factors altering ...
(Date:12/1/2015)... Minn. , Dec. 1, 2015  The Minnesota ... recipient of the 2015 Tekne Award in the Small ... at the Minneapolis Convention ... have played a significant role in developing new technologies ... living around the world. Clostridium difficile ...
(Date:12/1/2015)... , Dec. 1, 2015  CardioCell LLC, a ... stem cells for cardiovascular indications, intends to proceed ... based on recommendations from a Heart Failure Advisory ... Scientific Advisory Board members . In a ... Phase IIa safety and efficacy data from CardioCell,s ...
Breaking Biology Technology: